KPV
Also known as: Lysine-Proline-Valine, Lys-Pro-Val, alpha-MSH (11-13), alpha-MSH C-terminal tripeptide
Anti-inflammatory tripeptide from alpha-MSH that lowers TNF-alpha and IL-1beta without causing pigmentation. Useful for gut inflammation (selective uptake in the inflamed colon) and skin. Dosed SubQ, oral, or topical.
Pharmacokinetics
- Half-life
- 30 min
- Time to peak
- 15 min
- Bioavailability
- 70%
- Dosing interval
- 24h
Administration
- Primary routes
- SubQ, Oral, Topical
- Category
- Healing & Repair
Safety Flags
- High immunogenicity
- Contraindicated in cancer history
Storage
- · Requires refrigeration (2–8°C)
- · Temperature sensitive — minimise room-temp exposure
Used in 4 outcome protocols
- Skin Elasticity
Promote collagen synthesis and skin regeneration for improved skin quality
Safe default: 250mcg · daily · SubQ
- Gut HealingPrimary
Repair intestinal barrier function and reduce gut permeability
Safe default: 250mcg · daily · SubQ
- Immune Regulation
Modulate and balance immune system function
Safe default: 250mcg · daily · SubQ
- InflammationPrimary
Reduce systemic inflammation and inflammatory markers
Safe default: 250mcg · daily · SubQ
Simulate KPV
Pinned.life runs a 1-compartment Bateman pharmacokinetic simulation against 38 peptides in real time. Build a stack, see serum-level curves, get warned about peak overlaps and drug-peptide interactions.